The influence of constraints on the efficient allocation of resources for HIV prevention.
暂无分享,去创建一个
Cliff C Kerr | Robyn M Stuart | Sherrie L Kelly | Rowan Martin-Hughes | David P Wilson | C. Kerr | R. Stuart | S. Kelly | R. Martin-Hughes | D. Wilson
[1] Isaac J Stopard,et al. The influence of constraints on the efficient allocation of resources for HIV prevention: authors' response. , 2019, AIDS.
[2] H. Haghparast-Bidgoli,et al. Applying the ‘no-one worse off’ criterion to design Pareto efficient HIV responses in Sudan and Togo , 2019, AIDS.
[3] Maarten J. IJzerman,et al. Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force. , 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] Kelsey L. Grantham,et al. How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries , 2018, Journal of the International AIDS Society.
[5] Kelsey L. Grantham,et al. The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS. , 2018, The lancet. HIV.
[6] Kelsey L. Grantham,et al. Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions , 2018, BMC Public Health.
[7] A. Gawande,et al. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition , 2017, The Lancet.
[8] Cliff C. Kerr,et al. Maximizing the impact of malaria funding through allocative efficiency: using the right interventions in the right locations , 2017, Malaria Journal.
[9] Feng Zhao,et al. Optimizing investments in Belarus' Tuberculosis response , 2017 .
[10] Maarten J. IJzerman,et al. Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] Emiko Masaki,et al. Kazakhstan can achieve ambitious HIV targets despite expected donor withdrawal by combining improved ART procurement mechanisms with allocative and implementation efficiencies , 2017, PloS one.
[12] N. Tromp,et al. Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints , 2017, PLoS medicine.
[13] L. Johnson,et al. Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered? , 2017, BMC Public Health.
[14] T. Bärnighausen,et al. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness , 2016, AIDS.
[15] David P. Wilson,et al. In the interests of time: improving HIV allocative efficiency modelling via optimal time-varying allocations , 2016, Journal of the International AIDS Society.
[16] Cliff C Kerr,et al. Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization , 2015, Journal of acquired immune deficiency syndromes.
[17] David P. Wilson,et al. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study. , 2015, The lancet. HIV.
[18] B. Eampokalap,et al. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[19] S. Blower,et al. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: The effect of the urban–rural divide , 2006, Proceedings of the National Academy of Sciences.
[20] David P. Wilson,et al. Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries , 2005, PLoS medicine.